The overarching goal of this NRSA application is to provide a high quality, mentored training experience to develop future thought leaders in cardiovascular clinical research. We will recruit the most promising post- doctoral cardiology fellows into an optimized clinical research training program that includes: 1) rigorous didactic training in the methods of clinical research, 2) closely mentored, real world research experience, and 3) structured training and experience in survival skills required for a successful academic career. Trainees will spend at least 2 years in this program and devote 100% effort to the program while they are supported. We are requesting 6 trainee slots at the post-doctoral level. We have selected mentors for the program from among the thought leaders in cardiovascular clinical research at Duke. Interdisciplinary co-mentoring will be required, with each trainee co-mentored by a Duke methodologist. In addition, trainees will be able to select additional co-mentors from among the excellent faculty participating in this program as well as from among other Duke faculty, depending on each trainee's needs and research interests. Finally, our program will offer extramural career and research mentoring from some of cardiology's most respected and renowned leaders at top academic clinical research programs. For each trainee, several methods will be used to monitor progress, including the creation of a formal Individual Development Plan that will be reviewed regularly by a Scientific Oversight Committee and annually by an External Advisory Board. External mentors from among the Advisory Board will also provide robust assessments of our trainees and our program. Outcomes expected from each fellow accepted into this T32 program will include scientific presentations at research conferences/symposia and at national meetings, peer-reviewed publications, an independent research project, and at least one grant application to support the trainee's post-fellowship research. The Program Directors, faculty, and External Advisory Committee will assist each graduate in obtaining a faculty position in academics and will further guide and support them as they transition to independent investigators. The proposed NRSA program will organize the abundant resources available at Duke for clinical research into a focused and efficient program for training the cardiovascular clinical research thought leaders of the future.

Public Health Relevance

The purpose of this grant is to train the next generation of thought leaders in cardiovascular clinical research. These clinical researchers will bring scientific advancements in the care of patients with cardiovascular disease from bench to bedside through large-scale human testing in clinical trials, comparative effectiveness research, patient-centered health services research, outcomes research, and precision medicine research in addition to optimizing systems of care to promote high quality treatment patterns. Trainees supported by this grant are expected to make major scientific contributions to medicine in their academic research careers and have a significant impact on public health.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Scott, Jane
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Fanaroff, Alexander C; Zakroysky, Pearl; Wojdyla, Daniel et al. (2018) Relationship Between Operator Volume and Long-Term Outcomes after Percutaneous Coronary Intervention: A Report from the NCDR CathPCI Registry. Circulation :
Friedman, Daniel J; Fudim, Marat; Overton, Robert et al. (2018) The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients. Am Heart J 201:17-24
Vaduganathan, Muthiah; Cheema, Baljash; Cleveland, Erin et al. (2018) Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial. Eur J Heart Fail 20:677-686
Cheema, Baljash; Ambrosy, Andrew P; Kaplan, Rachel M et al. (2018) Lessons learned in acute heart failure. Eur J Heart Fail 20:630-641
Greene, Stephen J; Butler, Javed; Fonarow, Gregg C et al. (2018) Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. Eur J Heart Fail 20:281-291
Friedman, Daniel J; Parzynski, Craig S; Heist, E Kevin et al. (2018) Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry. Circulation 137:2463-2477
Vaduganathan, Muthiah; Samman Tahhan, Ayman; Greene, Stephen J et al. (2018) Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16 years. Eur J Heart Fail 20:1068-1071
Fudim, Marat; O'Connor, Christopher M; Dunning, Allison et al. (2018) Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail 20:304-314
Alenezi, Fawaz; Mandawat, Aditya; Il'Giovine, Zachary J et al. (2018) Clinical Utility and Prognostic Value of Right Atrial Function in Pulmonary Hypertension. Circ Cardiovasc Imaging 11:e006984
Friedman, Daniel J; Al-Khatib, Sana M (2018) Response by Friedman and Al-Khatib to Letter Regarding Article, ""Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry"". Circulation 138:2972-2973

Showing the most recent 10 out of 186 publications